|
|
Clinical study of Xuanjin Jiangni Decoction combined with Zuojin Pills in the treatment of reflux esophagitis |
WANG Kun1 WANG Juan2 SUI Xin3 LIU Xiaojin1 MA Aiwen4 |
1.Department of Pharmacy, Dezhou People’s Hospital, Shandong Province, Dezhou 253000, China;
2.Department of Internal Medicine, Qiancao Town Health Center of Pingyuan County of Dezhou City, Shandong Province, Pingyuan 253113, China; 3.Department of Gastroenterology, Dezhou People’s Hospital, Shandong Province, Dezhou 253000, China;
4.Department of Proctology, Dezhou Anorectal Hospital, Shandong Province, Dezhou 253000, China |
|
|
Abstract Objective To explore clinical effect of Xuanjin Jiangni Decoction combined with Zuojin Pills in the treatment of reflux esophagitis (RE). Methods Eighty patients with newly diagnosed RE in Dezhou People’s Hospital of Shandong Province from December 2018 to December 2019 were selected and divided into control group and study group according to random number table method, with 100 cases in each group. Control group was treated with conventional Western medicine, and study group was treated with Xuanjin Jiangni Decoction combined with Zuojin Pills. Clinical efficacy, Chinese medicine syndrome score, serological indicators and adverse reactions were compared between two groups. Results Total effective rate of study group was higher than that of control group (P < 0.05). After treatment, the scores of acid regurgitation, poststernal burning, irritability, upset, dry mouth and bitter mouth and constipation in two groups were lower than those before treatment, and the scores in study group were lower than those in control group, the differences were statistically significant (P < 0.05). After treatment, the levels of motilin (MOT) and gastrin (GAS) in two groups were higher than those before treatment, the levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in two groups were lower than those before treatment, and the levels of MOT and GAS in study group were higher than those in control group, and the levels of TNF-α and IL-6 in study group were lower than those in control group, the differences were statistically significant (P < 0.05). There was no significant difference in the incidence rate of adverse reactions between two groups (P > 0.05). Conclusion Xuanjin Jiangni Decoction combined with Zuojin Pills is safe and effective in the treatment of RE, which can effectively improve the clinical symptoms. Its mechanism may be related to the improvement of serum GAS, TNF-α, MOT and IL-6 levels.
|
|
|
|
|
[1] Heidinger M,Gorkiewicz G,Freisinger O,et al. Ulcerative reflux esophagitis associated with Clostridium ventriculi following hiatoplasty-is antibiotic treatment necessary? A case report [J]. Z Gastroenterol,2020,58(5):456-460.
[2] Na HK,Lee JH,Park SJ,et al. Effect of Helicobacter pylori eradication on reflux esophagitis and GERD symptoms after endoscopic resection of gastric neoplasm:a single-center prospective study [J]. BMC Gastroenterol,2020,20(1):123.
[3] Takenouchi N,Hoshino S,Hoshikawa Y,et al. Risk of hemorrhage and stricture significantly increases in elderly patients with proton pump inhibitor(PPI)-resistant reflux esophagitis [J]. Esophagus,2020,17(1):87-91.
[4] 王三强,许敏光,魏会珍,等.反流性食管炎中医学研究进展[J].陕西中医,2020,41(2):266-268.
[5] 马英歌,张艳丽,张晓楠,等.柴芍六君汤联合左金丸治疗肝胃郁热型反流性食管炎临床研究[J].新中医,2019, 51(1):78-82.
[6] 黄天生,郭召平,罗瑞萍,等.旋金降逆汤联合电针足三里治疗反流性食管炎(肝胃郁热证)临床研究[J].辽宁中医杂志,2019,46(11):2331-2334.
[7] 张声生,唐旭东,黄穗平,等.慢性胃炎中医诊疗专家共识意见(2017)[J].中华中医药杂志,2017,32(7):238-242.
[8] 中华医学会消化病学分会.2014年中国胃食管反流病专家共识意见[J].中华消化杂志,2014,34(10):649-661.
[9] 中华医学会消化内镜学分会.反流性食管炎诊断及治疗指南(2003年)[J].中华消化内镜杂志,2004,21(4):221-222.
[10] Gotoh Y,Ishibashi E,Honda S,et al. Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis,nonerosive esophagitis,and proton pump inhibitor-resistant gastroesophageal reflux disease [J]. Medicine(Baltimore),2020,99(11):e19520.
[11] 孙彬,王生,张丽敏.老年幽门螺杆菌感染与反流性食管炎的相关性研究[J].中华保健医学杂志,2019,21(6):542-544.
[12] Yalaki S,Pulat H,Ilhan A. Localization of Helicobacter pylori gastritis and the relation of existing histopathological features with reflux esophagitis [J]. Scand J Gastroenterol,2020,55(1):27-33.
[13] 王雨,郭喜军,张晓玉,等.郭喜军教授应用“调肺止酸”学说治疗反流性食管炎研究[J].河北中医药学报,2020, 35(1):57-59.
[14] Shilpa C,Sandeep S,Chandresh S,et al. Laryngopharyngeal reflux and GERD:correlation between reflux symptom index and reflux finding score [J]. Indian J Otolaryngol Head Neck Surg,2019,71(Suppl 1):684-688.
[15] 余英,高峰,张杰.反流性食管炎治疗效果与食管下段菌群构成变化的关系研究[J].首都医科大学学报,2020, 41(2):243-248.
[16] 沈惠贤,张艳霞,赵虹.气滞胃痛颗粒联合莫沙必利治疗反流性食管炎的临床研究[J].现代药物与临床,2018, 33(3):555-559.
[17] 孙师云.枸橼酸莫沙必利治疗胃食管反流病的效果探析[J].当代医药论丛,2020,18(2):153-154.
[18] Dulla O,Sultana S,Shohag Hosen M. In vitro comparative quality evaluation of different brands of esomeprazole tablets available in selected community pharmacies in Dhaka,Bangladesh [J]. BMC Res Notes,2018,11(1):184.
[19] 刘丽莉.奥美拉唑与埃索美拉唑治疗胃溃疡的临床效果比较[J].中国医药指南,2019,17(33):191-192.
[20] 叶国苍,曾灵燕.莫沙必利联合奥美拉唑治疗反流性食管炎的临床疗效及安全性评价[J].中国医药科学,2019, 9(1):81-83.
[21] 张博,李乔,谢冰昕.左金丸治疗对肝火犯胃证反流性食管炎患者胃肠道自主神经功能的影响[J].世界中医药,2018,13(4):830-833.
[22] 王健,林柳兵,沈莹,等.疏肝和中汤联合雷贝拉唑治疗肝胃郁热型反流性食管炎临床研究[J].陕西中医,2020, 41(2):168-171.
[23] 吴晓华,黄智萍,江伟骏,等.旋金降逆汤对反流性食管炎肝胃郁热证患者焦虑、抑郁情绪影响的临床研究[J].中医药信息,2020,37(3):72-75.
[24] 张建表,高泽立,许辰.枳术宽中胶囊联合莫沙必利和雷贝拉唑钠治疗反流性食管炎临床疗效及对血清MOT、GAS与炎症因子的影响[J].中国中西医结合消化杂志,2019,27(3):168-171.
[25] 严满,杜昕,白雪,等.旋覆代赭汤加减治疗肝胃郁热型反流性食管炎临床研究[J].河南中医,2018,38(11):1643-1646.
[26] 郭阳青.针药并用治疗肝胃郁热型反流性食管炎临床 |
|
|
|